Table 1.
The BioFire BCID2 panel targets | ||
---|---|---|
Gram-negative bacteria | Gram-positive bacteria | Antimicrobial resistance genes |
Acinetobacter calcoaceticus–Acinetobacter baumannii complex | Enterococcus faecalis | Carbapenemases |
Bacteroides fragilis | Enterococcus faecium | IMP |
Enterobacterales | Listeria monocytogenes | KPC |
Enterobacter cloacae complex | Staphylococcus species | OXA-48-like |
E. coli | Staphylococcus aureus | NDM |
Klebsiella aerogenes | Staphylococcus epidermidis | VIM |
Klebsiella oxytoca | Staphylococcus lugdunensis | Colistin resistance |
K. pneumoniae group | Streptococcus species | mcr-1 |
Proteus species | Streptococcus agalactiae | ESBL |
Salmonella species | Streptococcus pneumoniae | CTX-M |
Serratia marcescens | Streptococcus pyogenes | Methicillin resistance |
Haemophilus influenzae | Yeast | mecA/C |
Neisseria meningitidis | Candida albicans | mecA/C and MREJ (MRSA) |
P. aeruginosa | Candida auris | Vancomycin resistance |
Stenotrophomonas maltophilia | Candida glabrata | vanA/B |
Candida krusei | ||
Candida parapsilosis | ||
Candida tropicalis | ||
Cryptococcus neoformans/Cryptococcus gattii |
MRSA, methicillin-resistant staphylococcus aureus; MREJ, mec right extremity junction;